Literature DB >> 20651406

Increased ERCC1 protein expression is associated with suboptimal debulking in advanced epithelial ovarian cancer.

Feili Lin1, Kaiqing Lin, Xing Xie, Caiyun Zhou.   

Abstract

UNLABELLED: Some biological features, such as amount of ascites and molecular tissue markers, have been found to correlate with debulking outcome in advanced epithelial ovarian cancer (EOC). This study investigated whether proteins involved in nucleotide excision repair of EOC affected the debulking outcome. PATIENTS AND METHODS: The relationship between dichotomised clinical characteristics, ERCC1 and XPD protein expression levels in 78 patients were tested by univariate and multivariate analysis to determine the independent significance of factors for debulking outcome. Receiver operating characteristic (ROC) curves were constructed to determine their predictive value.
RESULTS: Pre- and postoperative CA125, ascites, menopause, and ERCC1 protein all significantly correlated with debulking outcome. However, only ERCC1 was the only independent factor, with the area under the ROC curve being 0.724.
CONCLUSION: ERCC1 protein is an independent prognostic indicator for debulking outcome in advanced EOC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20651406

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Analysis of Omics Data Reveals Nucleotide Excision Repair-Related Genes Signature in Highly-Grade Serous Ovarian Cancer to Predict Prognosis.

Authors:  Danian Dai; Qiang Li; Pengfei Zhou; Jianjiang Huang; Hongkai Zhuang; Hongmei Wu; Bo Chen
Journal:  Front Cell Dev Biol       Date:  2022-06-13

2.  Reversing drug resistance of cisplatin by hsp90 inhibitors in human ovarian cancer cells.

Authors:  Zhengmao Zhang; Zhen Xie; Guangyu Sun; Pingfang Yang; Jia Li; Hongfang Yang; Shuang Xiao; Yang Liu; Hongbing Qiu; Lijun Qin; Chao Zhang; Fenghua Zhang; Baoen Shan
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 3.  Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review.

Authors:  J Borley; C Wilhelm-Benartzi; R Brown; S Ghaem-Maghami
Journal:  Br J Cancer       Date:  2012-08-30       Impact factor: 7.640

4.  ADH1B promotes mesothelial clearance and ovarian cancer infiltration.

Authors:  Kshipra M Gharpure; Olivia D Lara; Anil K Sood; Yunfei Wen; Sunila Pradeep; Chris LaFargue; Cristina Ivan; Rajesha Rupaimoole; Wei Hu; Lingegowda S Mangala; Sherry Y Wu; Archana S Nagaraja; Keith Baggerly
Journal:  Oncotarget       Date:  2018-05-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.